Bank of America’s Pacira BioSciences PCRX Stock Holding History

Bank of America’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,000	Closed	-$1.74M	–	7435
2019 Q2	$1.74M	Buy	+40,000	New	+$1.7M	﹤0.01%	4142
2018 Q1	–	Sell	-38,600	Closed	-$1.76M	–	7275
2017 Q4	$1.76M	Buy	+38,600	New	+$1.53M	﹤0.01%	4066
2017 Q2	–	Sell	-58,300	Closed	-$2.66M	–	7110
2017 Q1	$2.66M	Buy	+58,300	New	+$2.52M	﹤0.01%	3619
2016 Q3	–	Sell	-25,000	Closed	-$843K	–	7297
2016 Q2	$843K	Buy	+25,000	New	+$1.23M	﹤0.01%	4303

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's PCRX Position: Q1 2026 in Review

Bank of America increased its Pacira BioSciences (PCRX) stake by 2% in Q1 2026, buying an estimated $80.7K and bringing the position to 188,437 shares worth $4.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3591.

Bank of America first reported a position in PCRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.5M in Q1 2024. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

Bank of America held 188,437 shares of Pacira BioSciences worth $4.26M as of Q1 2026.
Bank of America bought 3,630 Pacira BioSciences shares in Q1 2026, an estimated $80.7K.
Pacira BioSciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3591 holding.
Bank of America first reported a position in Pacira BioSciences in Q2 2013 and has held it in 52 quarters since.
Bank of America's Pacira BioSciences position peaked at $17.5M in Q1 2024.
241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.